SCHEMBL20324203

SCHEMBL20324203

CCOCCOCCOCCCOCCOCCNCC(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TSHR P16473 2/20 0.35
SCN1A P35498 1/20 0.34
SCN2A Q99250 1/20 0.34
SCN3A Q9NY46 1/20 0.34
KDM4E B2RXH2 3/20 0.33
POLB P06746 1/20 0.33
RECQL P46063 1/20 0.33
THRB P10828 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
EPHX2 P34913 4/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
HRH4 Q9H3N8 2/20 0.32
HRH3 Q9Y5N1 2/20 0.32
NPC1 O15118 1/20 0.31
HPGD P15428 1/20 0.31
RAB9A P51151 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20322535 0.98 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2TSHRSCN1ASCN2A
SCHEMBL22047323 0.94 SCN1A (0.37) ALDH1A1SMN1; SMN2TSHRSCN1ASCN2A
SCHEMBL26403759 0.94 SCN1A (0.37) ALDH1A1SMN1; SMN2TSHRSCN1ASCN2A
SCHEMBL18551478 0.94 SCN1A (0.37) ALDH1A1SMN1; SMN2TSHRSCN1ASCN2A
SCHEMBL20230907 0.94 SCN1A (0.37) ALDH1A1SMN1; SMN2TSHRSCN1ASCN2A
SCHEMBL20076069 0.94 SCN1A (0.37) ALDH1A1SMN1; SMN2TSHRSCN1ASCN2A
SCHEMBL20322537 0.90 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2TSHRKDM4EPOLB
SCHEMBL20231617 0.89 SMN1; SMN2 (0.40) ALDH1A1SMN1; SMN2TSHRKDM4EPOLB
SCHEMBL23560061 0.86 TSHR (0.41) ALDH1A1SMN1; SMN2TSHRSCN1ASCN2A
SCHEMBL22802798 0.86 TSHR (0.41) ALDH1A1SMN1; SMN2TSHRSCN1ASCN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3660004-B1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR ARVINAS OPERATIONS INC (US) 2023-02-22 EP disclosed
EP-3660004-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR Arvinas Operations, Inc. (US) 2020-06-03 EP disclosed
WO-2018119448-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES Arvinas, Inc. (US) 2018-06-28 WO disclosed